White House picks lead for FDA

March 10, 2017
President Trump has nominated Scott Gottlieb, MD, to lead the U.S. Food and Drug Administration (FDA).  In the past, Dr. Gottlieb has stated that administrative red tape is preventing competition in the drug manufacturing industry, and if confirmed, he would likely have an integral role in President Trump’s efforts to speed up the drug-approval process.

Dr. Gottlieb has a medical degree from Mount Sinai School of Medicine and did his residency in internal medicine at the Mount Sinai Medical Center. Dr. Gottlieb previously served as a deputy commissioner of the FDA under President George W. Bush.